Sign In
Buy CPHRF
$11.93
-0.133 (-1.10%)
At Close: Jun 03, 2026
Cipher Pharmaceuticals Inc. (CPH:CA) Q1 2026 Earnings Call Transcript
10:21am, Friday, 08'th May 2026
Cipher Pharmaceuticals Inc. (CPH:CA) Q1 2026 Earnings Call Transcript
CaryHealth Launches Direct-to-Patient Program for Cipher Pharmaceuticals' Natroba™ (spinosad)
09:07am, Tuesday, 07'th Apr 2026
WASHINGTON--(BUSINESS WIRE)-- #DTP--CaryHealth, a leading digital health company, today announced the launch of its direct-to-patient (DTP) platform to support seamless access to Natroba (spinosad), a
Cipher Pharmaceuticals (OTCMKTS:CPHRF) Stock Price Crosses Above 50 Day Moving Average – Should You Sell?
03:14am, Tuesday, 31'st Mar 2026
Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF - Get Free Report) (TSE: CPH)'s share price passed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $
Cipher Pharmaceuticals Inc. (CPH:CA) Q4 2025 Earnings Call Transcript
09:52am, Friday, 13'th Mar 2026
Cipher Pharmaceuticals Inc. (CPH:CA) Q4 2025 Earnings Call Transcript
Cipher Pharmaceuticals (OTCMKTS:CPHRF) Stock Price Passes Above Fifty Day Moving Average – Should You Sell?
03:54am, Saturday, 10'th Jan 2026
Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF - Get Free Report) (TSE: CPH)'s stock price passed above its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $10.40
Cipher Pharmaceuticals Inc. (CPH:CA) Q3 2025 Earnings Call Transcript
03:56pm, Friday, 07'th Nov 2025
Cipher Pharmaceuticals Inc. ( CPH:CA ) Q3 2025 Earnings Call November 7, 2025 8:30 AM EST Company Participants Craig Mull - Interim CEO & Chairman of the Board Ryan Mailling - Chief Financial Officer
Halvio Capital Q3 2025 Position Updates
03:30am, Tuesday, 07'th Oct 2025
FILA declined during the quarter as a result of an analyst downgrade amidst an uncertain US outlook. During the quarter NLOP paid its first, and hopefully many more, special dividend of $3.10/share to
Cipher Pharmaceuticals Inc. (CPHRF) Q2 2025 Earnings Call Transcript
04:04pm, Friday, 08'th Aug 2025
Cipher Pharmaceuticals Inc. (OTCQX:CPHRF) Q2 2025 Earnings Conference Call August 8, 2025 8:30 AM ET Company Participants Bryan Jacobs - President Craig J. Mull - Interim CEO & Chairman of the Board R
Cipher Pharmaceuticals Inc. (CPHRF) Q1 2025 Earnings Call Transcript
12:01pm, Friday, 09'th May 2025
Cipher Pharmaceuticals Inc. (OTCQX:CPHRF) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Ryan Mailling - Chief Financial Offi
Most Topical Earnings Summaries And Commentary For April 2025
07:15am, Wednesday, 23'rd Apr 2025
Goeasy and Propel stocks are undervalued due to macroeconomic fears, but their fundamentals are strong, presenting a significant rebound opportunity. Zedcor's US expansion and new product success indi
Cipher Pharmaceuticals Inc. (CPHRF) Q4 2024 Earnings Call Transcript
11:04am, Wednesday, 19'th Mar 2025
Cipher Pharmaceuticals Inc. (OTCQX:CPHRF) Q4 2024 Earnings Conference Call March 19, 2025 8:30 AM ET Company Participants Craig Mull - Interim CEO Ryan Mailling – CFO Bryan Jacobs - President of U.S
Cipher Pharmaceuticals Inc. (CPHRF) Q1 2024 Earnings Call Transcript
10:06am, Friday, 10'th May 2024
Cipher Pharmaceuticals Inc. (OTCQX:CPHRF) Q1 2024 Earnings Conference Call May 10, 2024 8:30 AM ET Company Participants Craig J. Mull - Interim CEO Bryan Jacobs - CFO Conference Call Participants Andr
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
07:05am, Wednesday, 03'rd Apr 2024
Mississauga, Ontario--(Newsfile Corp. - April 3, 2024) - Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which wil
Cipher Pharmaceuticals Inc. (CPHRF) Q3 2023 Earnings Call Transcript
10:37am, Friday, 10'th Nov 2023
Cipher Pharmaceuticals Inc. (OTCPK:CPHRF) Q3 2023 Earnings Conference Call November 10, 2023 8:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Bryan Jacobs - Chief Financial
Cipher Pharmaceuticals Inc. (CPHRF) Q2 2023 Earnings Call Transcript
12:25pm, Friday, 11'th Aug 2023
Start Time: 08:30 January 1, 0000 9:00 AM ET Cipher Pharmaceuticals Inc. (OTCPK:CPHRF) Q2 2023 Earnings Conference Call August 11, 2023, 08:30 AM ET Company Participants Craig Mull - Interim CEO Bryan
